tiprankstipranks
Advertisement
Advertisement

RPTX Stock Latest News

RPTX Upcoming Earnings Report: What to Expect?
Pre-EarningsRPTX Upcoming Earnings Report: What to Expect?
5M ago
RPTX
Repare Therapeutics completes acquisition and goes private
PremiumCompany Announcements
Repare Therapeutics completes acquisition and goes private
6M ago
8K
RPTX
Repare Therapeutics Shareholders Approve Acquisition by XenoTherapeutics
PremiumCompany Announcements
Repare Therapeutics Shareholders Approve Acquisition by XenoTherapeutics
7M ago
8K
RPTX
Repare Therapeutics shareholders approve acquisition by XenoTherapeutics
PremiumThe Fly
Repare Therapeutics shareholders approve acquisition by XenoTherapeutics
7M ago
RPTX
Repare Therapeutics Sells RP-3467 Cancer Program Assets to Gilead for Up to $30 Million
PremiumCompany Announcements
Repare Therapeutics Sells RP-3467 Cancer Program Assets to Gilead for Up to $30 Million
7M ago
RPTX
Repare Therapeutics Sells RP-3467 Program to Gilead
PremiumCompany AnnouncementsRepare Therapeutics Sells RP-3467 Program to Gilead
7M ago
8K
RPTX
Repare Sells Key Oncology Asset to Gilead, Lifts Expected Xeno Deal Payout
Premium
Company Announcements
Repare Sells Key Oncology Asset to Gilead, Lifts Expected Xeno Deal Payout
7M ago
RPTX
Repare Therapeutics announces Gilead to acquire RP-3467 for up to $30M
Premium
The Fly
Repare Therapeutics announces Gilead to acquire RP-3467 for up to $30M
7M ago
GILD
RPTX
Repare Therapeutics announces CSO resignation and transition plan
PremiumCompany Announcements
Repare Therapeutics announces CSO resignation and transition plan
8M ago
8K
RPTX
Repare Therapeutics Announces Shareholder Meeting for Acquisition Approval
PremiumCompany Announcements
Repare Therapeutics Announces Shareholder Meeting for Acquisition Approval
8M ago
RPTX
Repare Therapeutics Reports Positive Q3 2025 Results
PremiumCompany Announcements
Repare Therapeutics Reports Positive Q3 2025 Results
9M ago
RPTX
Repare Therapeutics Announces Acquisition by XenoTherapeutics
PremiumCompany Announcements
Repare Therapeutics Announces Acquisition by XenoTherapeutics
9M ago
8K
RPTX
Repare Therapeutics downgraded to Hold from Buy at TD Cowen
PremiumThe FlyRepare Therapeutics downgraded to Hold from Buy at TD Cowen
9M ago
RPTX
Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move
Premium
Company Announcements
Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move
9M ago
RPTX
Repare Therapeutics trading resumes
Premium
The Fly
Repare Therapeutics trading resumes
9M ago
RPTX
Repare Therapeutics reports Q3 EPS 8c vs. (81c) last year
PremiumThe Fly
Repare Therapeutics reports Q3 EPS 8c vs. (81c) last year
9M ago
RPTX
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
PremiumThe Fly
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
9M ago
RPTX
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
PremiumThe Fly
XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
9M ago
RPTX
Repare Therapeutics trading halted, news pending
PremiumThe Fly
Repare Therapeutics trading halted, news pending
9M ago
RPTX
Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look
PremiumCompany AnnouncementsRepare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look
9M ago
RPTX
Repare Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
Premium
The Fly
Repare Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
9M ago
RPTX
Repare Therapeutics Unveils Phase 1 LIONS Trial Data
Premium
Company Announcements
Repare Therapeutics Unveils Phase 1 LIONS Trial Data
9M ago
8K
RPTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >